TRAVERTINE

Hazard statements (CLP)

H315, H318

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

Hazard labelling pursuant to EC Regulation 1272/2008 (CLP) and subsequent amendments and supplements. Classification of the substance or mixture

Signal word

Danger

Hazard statements

H318 Causes serious eye damage. H315 Causes skin irritation.

Precautionary statements

P101 If medical advice is needed, have product container or label at hand. P102 Keep out of reach of children. P103 Read label before use. P280 Wear protective gloves/ protective clothing / eye protection / face protection. P302+P352 IF ON SKIN: Wash with plenty of water / . . . P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P501 Dispose of contents/container according to local regulation.

Contains

CALCIUM HYDROXIDE VOC (Directive 2004/42/EC) Interior matt walls and ceilings (Gloss < 25@60°). VOC given in g/litre of product in a ready-to-use condition 30,00 Limit value: 30,00

2.3 Other hazards

On the basis of available data, the product does not contain any PBT or vPvB in percentage ≥ than 0,1%. The product does not contain substances with endocrine disrupting properties in concentration ≥ 0.1%.

2.1 Classification of the substance or mixture

The product is classified as hazardous pursuant to the provisions set forth in (EC) Regulation 1272/2008 (CLP) (and subsequent amendments and supplements). The product thus requires a safety datasheet that complies with the provisions of (EU) Regulation 2020/878. Any additional information concerning the risks for health and/or the environment are given in sections 11 and 12 of this sheet. Hazard classification and indication: Serious eye damage, category 1 H318 Causes serious eye damage. Skin irritation, category 2 H315 Causes skin irritation. The classification of the compound, featuring an extreme pH value, is based on the results of an appropriate in vitro test.